Hongliang Wang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Henan Institute of Science and Technology, Chongqing Medical University · ORCID：0000-0002-5905-3225

发表论文 34 篇 · 总被引 749 次 · h-index 16

代表论文

• Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma (2020 · Bioactive Materials · 被引 112)
• <p>Self-Assembled Lecithin/Chitosan Nanoparticles Based on Phospholipid Complex: A Feasible Strategy to Improve Entrapment Efficiency and Transdermal Delivery of Poorly Lipophilic Drug</p> (2020 · International Journal of Nanomedicine · 被引 79)
• Mechanism Study on Nanoparticle Negative Surface Charge Modification by Ascorbyl Palmitate and Its Improvement of Tumor Targeting Ability (2022 · Molecules · 被引 53)
• Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity (2021 · Journal for ImmunoTherapy of Cancer · 被引 52)
• Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle (2018 · Journal of Controlled Release · 被引 49)
• Unlocking the potential of amorphous calcium carbonate: A star ascending in the realm of biomedical application (2023 · Acta Pharmaceutica Sinica B · 被引 39)